Research data to accommodate the article "Overlay journals: a study of the current landscape" (https://doi.org/10.1177/09610006221125208)

Identifying the sample of overlay journals was an explorative process (occurring during April 2021 to February 2022). The sample of investigated overlay journals were identified by using the websites of Episciences.org (2021), Scholastica (2021), Free Journal Network (2021), Open Journals (2021), PubPub (2022), and Wikipedia (2021). In total, this study identified 34 overlay journals. Please see the paper for more details about the excluded journal types.

The journal ISSN numbers, manuscript source repositories, first overlay volumes, article volumes, publication languages, peer-review type, licence for published articles, author costs, publisher types, submission policy, and preprint availability policy were observed by inspecting journal editorial policies and submission guidelines found from journal websites. The overlay journals’ ISSN numbers were identified by examining journal websites and cross-checking this information with the Ulrich’s periodicals database (Ulrichsweb, 2021). Journals that published review reports, either with reviewers’ names or anonymously, were classified as operating with open peer-review. Publisher types defined by Laakso and Björk (2013) were used to categorise the findings concerning the publishers. If the journal website did not include publisher information, the editorial board was interpreted to publish the journal.

The Organisation for Economic Co-operation and Development (OECD) field of science classification was used to categorise the journals into different domains of science. The journals’ primary OECD field of sciences were defined by the authors through examining the journal websites.

Whether the journals were indexed in the Directory of Open Access Journals (DOAJ), Scopus, or Clarivate Analytics’ Web of Science Core collection’s journal master list was examined by searching the services with journal ISSN numbers and journal titles.

The identified overlay journals were examined from the viewpoint of both qualitative and quantitative journal metrics. The qualitative metrics comprised the Nordic expert panel rankings of scientific journals, namely the Finnish Publication Forum, the Danish Bibliometric Research Indicator and the Norwegian Register for Scientific Journals, Series and Publishers. Searches were conducted from the web portals of the above services with both ISSN numbers and journal titles. Clarivate Analytics’ Journal Citation Reports database was searched with the use of both ISSN numbers and journal titles to identify whether the journals had a Journal Citation Indicator (JCI), Two-Year Impact Factor (IF) and an Impact Factor ranking (IF rank). The examined Journal Impact Factors and Impact Factor rankings were for the year 2020 (as released in 2021).

Academic journals indicators developed from the information contained in the Scopus database (Elsevier B.V.). These indicators can be used to assess and analyze scientific domains.

Data and code for manuscript:

David B Resnik, Melissa Morales, Rachel Landrum, Min Shi, Jessica Minnier, Nicole A. Vasilevsky & Robin E. Champieux (2019) Effect of Impact Factor and Discipline on Journal Data Sharing Policies, Accountability in Research, DOI: 10.1080/08989621.2019.1591277

Zenodo pre-print DOI: https://doi.org/10.5281/zenodo.2592682

Data collection utilized three sources:

• 2016 InCites Journal Citations Report
• Directory of Open Access Journal
• Journal websites and author guidelines

The data was collected and analyzed between May 2018 and October 2018.

Data and Code

Data can be found in data/if-discipline-datasharing-policy-rawdata-1.0.0.csv.

Analysis code for tables and figures can be seen in code/analysis_report.md (author of code: Jessica Minnier, OHSU, @jminnier)

An Overview on the twenty journals with the highest Journal Impact Factors within the Subject Category General & Internal Medicine and their status as Open Access or Closed Access Journals.

IScience Impact Factor 2024-2025 - ResearchHelpDesk - Science has many big remaining questions. To address them, we will need to work collaboratively and across disciplines. The goal of iScience is to help fuel that type of interdisciplinary thinking. iScience is a new open-access journal from Cell Press that provides a platform for original research in the life, physical, earth, and health sciences. The primary criterion for publication in iScience is a significant contribution to a relevant field combined with robust results and underlying methodology. The advances appearing in iScience include both fundamental and applied investigations across this interdisciplinary range of topic areas. To support transparency in scientific investigation, we are happy to consider replication studies and papers that describe negative results. We know you want your work to be published quickly and to be widely visible within your community and beyond. With the strong international reputation of Cell Press behind it, publication in iScience will help your work garner the attention and recognition it merits. Like all Cell Press journals, iScience prioritizes rapid publication. Our editorial team pays special attention to high-quality author service and to efficient, clear-cut decisions based on the information available within the manuscript. iScience taps into the expertise across Cell Press journals and selected partners to inform our editorial decisions and help publish your science in a timely and seamless way. iScience is a fully gold open access journal. To provide open access, expenses are offset by an author publication fee that allows the journal to support itself and the research community in a fully sustainable way. iScience has a small budget for reducing open access charges for authors in developing countries and others in genuine financial hardship. Please note that funds for other reductions are limited.

Journal of Chemistry Acceptance Rate - ResearchHelpDesk - Journal of Chemistry is a peer-reviewed, Open Access journal that publishes original research articles as well as review articles on all aspects of fundamental and applied chemistry. Journal of Chemistry is archived in Portico, which provides permanent archiving for electronic scholarly journals, as well as via the LOCKSS initiative. It operates a fully open access publishing model which allows open global access to its published content. This model is supported through Article Processing Charges. Journal of Chemistry is included in many leading abstracting and indexing databases. For a complete list, click here. The most recent Impact Factor for Journal of Chemistry is 1.727 according to the 2018 Journal Citation Reports released by Clarivate Analytics in 2019. The journal’s most recent CiteScore is 1.32 according to the CiteScore 2018 metrics released by Scopus. Abstracting and Indexing Academic Search Alumni Edition Academic Search Complete AgBiotech Net AgBiotech News and Information AGRICOLA Agricultural Economics Database Agricultural Engineering Abstracts Agroforestry Abstracts Animal Breeding Abstracts Animal Science Database Biofuels Abstracts Botanical Pesticides CAB Abstracts Chemical Abstracts Service (CAS) CNKI Scholar Crop Physiology Abstracts Crop Science Database Directory of Open Access Journals (DOAJ) EBSCOhost Connection EBSCOhost Research Databases Elsevier BIOBASE - Current Awareness in Biological Sciences (CABS) EMBIOlogy Energy and Power Source Global Health Google Scholar J-Gate Portal Journal Citation Reports - Science Edition Open Access Journals Integrated Service System Project (GoOA) Primo Central Index Reaxys Science Citation Index Expanded Scopus Textile Technology Index The Summon Service WorldCat Discovery Services

Objective: To determine the top 100-ranked (by impact factor) clinical journals' policies toward publishing research previously published on preprint servers (preprints).

Design: Cross sectional. Main outcome measures: Editorial guidelines toward preprints, journal rank by impact factor.

Results: 86 (86%) of the journals examined will consider papers previously published as preprints (preprints), 13 (13%) determine their decision on a case-by-case basis, and 1 (1%) does not allow preprints.

Conclusions: We found wide acceptance of publishing preprints in the clinical research community, although researchers may still face uncertainty that their preprints will be accepted by all of their target journals.

Demographic information of focus groups participants.

Answers to a survey on gold Open Access run from July to October 2016. The dataset contains 15,235 unique responses from Web of Science published authors. This survey is part of a PhD thesis from the University of Granada in Spain. More details about the study can be found in the full text document, also available in Zenodo.

Following are listed the questions related to the WoS 2016 dataset. Please note that countries with less than 40 answers are listed as "Other" in order to preserve anonymity.

* 1. How many years have you been employed in research?

• Fewer than 5 years
• 5-14 years
• 15-24 years
• 25 years or longer

Many of the questions that follow concern Open Access publishing. For the purposes of this survey, an article is Open Access if its final, peer-reviewed, version is published online by a journal and is free of charge to all users without restrictions on access or use.

* 2. Do any journals in your research field publish Open Access articles?

• Yes
• No
• I do not know

* 3. Do you think your research field benefits, or would benefit from journals that publish Open Access articles?

• Yes
• No
• I have no opinion
• I do not care

* 4. How many peer reviewed research articles (Open Access or not Open Access) have you published in the last five years?

• 1-5
• 6-10
• 11-20
• 21-50
• More than 50

* 5. What factors are important to you when selecting a journal to publish in?

[Each factor may be rated “Extremely important”, “Important”, “Less important” or “Irrelevant”. The factors are presented in random order.]

• Importance of the journal for academic promotion, tenure or assessment
• Recommendation of the journal by my colleagues
• Positive experience with publisher/editor(s) of the journal
• The journal is an Open Access journal
• Relevance of the journal for my community
• The journal fits the policy of my organisation
• Prestige/perceived quality of the journal
• Likelihood of article acceptance in the journal
• Absence of journal publication fees (e.g. submission charges, page charges, colour charges)
• Copyright policy of the journal
• Journal Impact Factor
• Speed of publication of the journal

6. Who usually decides which journals your articles are submitted to? (Choose more than one answer if applicable)

• The decision is my own
• A collective decision is made with my fellow authors
• I am advised where to publish by a senior colleague
• The organisation that finances my research advises me where to publish
• Other (please specify) [Text box follows]

7. Approximately how many Open Access articles have you published in the last five years?

• 0
• 1-5
• 6-10
• More than 10
• I do not know

[If the answer is “0”, the survey jumps to Q10.]

* 8. What publication fee was charged for the last Open Access article you published?

• No charge
• Up to €250 ($275)
• €251-€500 ($275-$550)
• €501-€1000 ($551-$1100)
• €1001-€3000 ($1101-$3300)
• More than €3000 ($3300)
• I do not know

[If the answer is “No charge or I don’t know” the survey jumps to Q20. ]

* 9. How was this publication fee covered? (Choose more than one answer if applicable)

• My research funding includes money for paying such fees
• I used part of my research funding not specifically intended for paying such fees
• My institution paid the fees
• I paid the costs myself
• Other (please specify) [Text box follows]

* 10. How easy is it to obtain funding if needed for Open Access publishing from your institution or the organisation mainly responsible for financing your research?

• Easy
• Difficult
• I have not used these sources

* 11. Listed below are a series of statements, both positive and negative, concerning Open Access publishing. Please indicate how strongly you agree/disagree with each statement.

[Each statement may be rated “Strongly agree”, “Agree”, “Neither agree nor disagree”, “Disagree” or “Strongly disagree”. The statements are presented in random order.]

• Researchers should retain the rights to their published work and allow it to be used by others
• Open Access publishing undermines the system of peer review
• Open Access publishing leads to an increase in the publication of poor quality research
• If authors pay publication fees to make their articles Open Access, there will be less money available for research
• It is not beneficial for the general public to have access to published scientific and medical articles
• Open Access unfairly penalises research-intensive institutions with large publication output by making them pay high costs for publication
• Publicly-funded research should be made available to be read and used without access barrier
• Open Access publishing is more cost-effective than subscription-based publishing and so will benefit public investment in research
• Articles that are available by Open Access are likely to be read and cited more often than those not Open Access

This study and its questionnaire are based on the SOAP Project (http://project-soap.eu). An article describing the highlights of the SOAP Survey is available at: https://arxiv.org/abs/1101.5260. The dataset of the SOAP survey is available at http://bit.ly/gSmm71. A manual describing the SOAP dataset is available at http://bit.ly/gI8nc.

Plant Biotechnology Journal FAQ - ResearchHelpDesk - Plant Biotechnology Journal, an Open Access journal, publishes high-impact original research and incisive reviews with an emphasis on molecular plant sciences and their applications through plant biotechnology. Reasons to publish with Plant Biotechnology Journal High Impact Factor: 6.84 (in top 5 original research journals in plant sciences and number 1 Open Access journal in plant sciences). CiteScore: 6.88 (ranked number 1 among all Open Access journals in the plant sciences. Ranked number 1 among 320 agronomy and crop science journals) High standard, rigorous peer review. Broad dissemination with articles attracting high Altmetric scores. Open Access: fully compliant with Open Access mandates, articles are published under Creative Commons license and authors are the copyright holder. As an Open Access journal your research will be accessible globally without restriction. Our author centre provides promotional tools to help you maximise the impact of your article.

Journal of Oral Microbiology Impact Factor 2024-2025 - ResearchHelpDesk - As the first Open Access journal in its field, the Journal of Oral Microbiology aims to be an influential source of knowledge on the aetiological agents behind oral infectious diseases. The journal is an international forum for original research on all aspects of 'oral health'. Articles which seek to understand 'oral health' through exploration of the pathogenesis, virulence, host-parasite interactions, and immunology of oral infections are of particular interest. However, the journal also welcomes work that addresses the global agenda of oral infectious diseases and articles that present new strategies for treatment and prevention or improvements to existing strategies. Topics: Oral health, Microbiome, Genomics, Host-pathogen interactions, Oral infections, Aetiologic agents, Pathogenesis, Molecular microbiology systemic diseases, Ecology/environmental microbiology, Treatment, Diagnostics, Epidemiology, Basic oral microbiology, and taxonomy/systematics. Article types: Original articles, Notes, Review articles, Mini-reviews and commentaries. The Journal of Oral Microbiology is indexed/tracked/covered by the following services: AgBiotechNet (CABI) BIOSIS Previews (Clarivate Analytics) CAB Abstracts (CABI) CAS Directory of Open Access Journals (DOAJ) EMBASE (Elsevier) Global Health (CABI) Health Research Premium Collection HINARI Hospital Premium Collection JournalSeek Open Access Journals Integrated Service System Project (GoOA) Ornamental Horticulture (CABI) Parasitology Database (CABI) Pig News and Information (CABI) Plant Genetics and Breeding Database (CABI) Plant Growth Regulator Abstracts (CABI) ProQuest Central ProQuest Natural Science Collection ProQuest SciTech Collection PubMed (NLM) PubMed Central (NLM) Science Citation Index Expanded (Clarivate Analytics) ScienceOpen SciTech Premium Collection Scopus (Elsevier) Ulrich's Periodicals Directory

Background This bibliometric analysis examines the top 50 most-cited articles on COVID-19 complications, offering insights into the multifaceted impact of the virus. Since its emergence in Wuhan in December 2019, COVID-19 has evolved into a global health crisis, with over 770 million confirmed cases and 6.9 million deaths as of September 2023. Initially recognized as a respiratory illness causing pneumonia and ARDS, its diverse complications extend to cardiovascular, gastrointestinal, renal, hematological, neurological, endocrinological, ophthalmological, hepatobiliary, and dermatological systems. Methods Identifying the top 50 articles from a pool of 5940 in Scopus, the analysis spans November 2019 to July 2021, employing terms related to COVID-19 and complications. Rigorous review criteria excluded non-relevant studies, basic science research, and animal models. The authors independently reviewed articles, considering factors like title, citations, publication year, journal, impact factor, authors, study details, and patient demographics. Results The focus is primarily on 2020 publications (96%), with all articles being open-access. Leading journals include The Lancet, NEJM, and JAMA, with prominent contributions from Internal Medicine (46.9%) and Pulmonary Medicine (14.5%). China played a major role (34.9%), followed by France and Belgium. Clinical features were the primary study topic (68%), often utilizing retrospective designs (24%). Among 22,477 patients analyzed, 54.8% were male, with the most common age group being 26–65 years (63.2%). Complications affected 13.9% of patients, with a recovery rate of 57.8%. Conclusion Analyzing these top-cited articles offers clinicians and researchers a comprehensive, timely understanding of influential COVID-19 literature. This approach uncovers attributes contributing to high citations and provides authors with valuable insights for crafting impactful research. As a strategic tool, this analysis facilitates staying updated and making meaningful contributions to the dynamic field of COVID-19 research. Methods A bibliometric analysis of the most cited articles about COVID-19 complications was conducted in July 2021 using all journals indexed in Elsevier’s Scopus and Thomas Reuter’s Web of Science from November 1, 2019 to July 1, 2021. All journals were selected for inclusion regardless of country of origin, language, medical speciality, or electronic availability of articles or abstracts. The terms were combined as follows: (“COVID-19” OR “COVID19” OR “SARS-COV-2” OR “SARSCOV2” OR “SARS 2” OR “Novel coronavirus” OR “2019-nCov” OR “Coronavirus”) AND (“Complication” OR “Long Term Complication” OR “Post-Intensive Care Syndrome” OR “Venous Thromboembolism” OR “Acute Kidney Injury” OR “Acute Liver Injury” OR “Post COVID-19 Syndrome” OR “Acute Cardiac Injury” OR “Cardiac Arrest” OR “Stroke” OR “Embolism” OR “Septic Shock” OR “Disseminated Intravascular Coagulation” OR “Secondary Infection” OR “Blood Clots” OR “Cytokine Release Syndrome” OR “Paediatric Inflammatory Multisystem Syndrome” OR “Vaccine Induced Thrombosis with Thrombocytopenia Syndrome” OR “Aspergillosis” OR “Mucormycosis” OR “Autoimmune Thrombocytopenia Anaemia” OR “Immune Thrombocytopenia” OR “Subacute Thyroiditis” OR “Acute Respiratory Failure” OR “Acute Respiratory Distress Syndrome” OR “Pneumonia” OR “Subcutaneous Emphysema” OR “Pneumothorax” OR “Pneumomediastinum” OR “Encephalopathy” OR “Pancreatitis” OR “Chronic Fatigue” OR “Rhabdomyolysis” OR “Neurologic Complication” OR “Cardiovascular Complications” OR “Psychiatric Complication” OR “Respiratory Complication” OR “Cardiac Complication” OR “Vascular Complication” OR “Renal Complication” OR “Gastrointestinal Complication” OR “Haematological Complication” OR “Hepatobiliary Complication” OR “Musculoskeletal Complication” OR “Genitourinary Complication” OR “Otorhinolaryngology Complication” OR “Dermatological Complication” OR “Paediatric Complication” OR “Geriatric Complication” OR “Pregnancy Complication”) in the Title, Abstract or Keyword. A total of 5940 articles were accessed, of which the top 50 most cited articles about COVID-19 and Complications of COVID-19 were selected through Scopus. Each article was reviewed for its appropriateness for inclusion. The articles were independently reviewed by three researchers (JRP, MAM and TS) (Table 1). Differences in opinion with regard to article inclusion were resolved by consensus. The inclusion criteria specified articles that were focused on COVID-19 and Complications of COVID-19. Articles were excluded if they did not relate to COVID-19 and or complications of COVID-19, Basic Science Research and studies using animal models or phantoms. Review articles, Viewpoints, Guidelines, Perspectives and Meta-analysis were also excluded from the top 50 most-cited articles (Table 1). The top 50 most-cited articles were compiled in a single database and the relevant data was extracted. The database included: Article Title, Scopus Citations, Year of Publication, Journal, Journal Impact Factor, Authors, Number of Authors, Department Affiliation, Number of Institutions, Country of Origin, Study Topic, Study Design, Sample Size, Open Access, Non-Original Articles, Patient/Participants Age, Gender, Symptoms, Signs, Co-morbidities, Complications, Imaging Modalities Used and outcome.

ObjectiveThe San Francisco Declaration on Research Assessment (DORA) advocates for assessing biomedical research quality and impact, yet academic organizations continue to employ traditional measures such as Journal Impact Factor. We aimed to identify and prioritize measures for assessing research quality and impact.MethodsWe conducted a review of published and grey literature to identify measures of research quality and impact, which we included in an online survey. We assembled a panel of researchers and research leaders, and conducted a two-round Delphi survey to prioritize measures rated as high (rated 6 or 7 by ≥ 80% of respondents) or moderate (rated 6 or 7 by ≥ 50% of respondents) importance.ResultsWe identified 50 measures organized in 8 domains: relevance of the research program, challenges to research program, or productivity, team/open science, funding, innovations, publications, other dissemination, and impact. Rating of measures by 44 panelists (60%) in Round One and 24 (55%) in Round Two of a Delphi survey resulted in consensus on the high importance of 5 measures: research advances existing knowledge, research plan is innovative, an independent body of research (or fundamental role) supported by peer-reviewed research funding, research outputs relevant to discipline, and quality of the content of publications. Five measures achieved consensus on moderate importance: challenges to research productivity, potential to improve health or healthcare, team science, collaboration, and recognition by professional societies or academic bodies. There was high congruence between researchers and research leaders across disciplines.ConclusionsOur work contributes to the field by identifying 10 DORA-compliant measures of research quality and impact, a more comprehensive and explicit set of measures than prior efforts. Research is needed to identify strategies to overcome barriers of use of DORA-compliant measures, and to “de-implement” traditional measures that do not uphold DORA principles yet are still in use.

Nature Communications Acceptance Rate - ResearchHelpDesk - Nature Communications is an open-access journal that publishes high-quality research from all areas of the natural sciences. Papers published by the journal represent important advances of significance to specialists within each field. Nature Communications is open access, multidisciplinary journal dedicated to publishing high-quality research in all areas of the biological, health, physical, chemical, and Earth sciences. Papers published by the journal aim to represent important advances of significance to specialists within each field. We are committed to providing an efficient service for both authors and readers. Our team of independent editors makes rapid and fair publication decisions. Prompt dissemination of accepted papers to a wide readership and beyond is achieved through a program of continuous online publication. Article and journal metrics Article metrics such as number of downloads, citations and online attention are available from each article page and provide an overview of the attention received by a paper. The 2018 journal metrics for Nature Communications are as follows: 2-year Impact Factor: 11.878 5-year Impact Factor: 13.811 Immediacy Index: 2.107 Eigenfactor® score: 1.10329 Article Influence Score: 5.402 2-year Median: 8 Nature Communications Abstract & Indexing DOAJ, MEDLINE, Web of Science, Scopus and Google Scholar. Nature Communications started in the year 2010 and has been growing ever since. Nature Communications doesn’t have a fixed publishing frequency. Their publishing frequency is continuous and upon acceptance. They have a very strict acceptance rate of 7.7%. They get over 50,000+ submissions every year. Nature Communications Article-processing charges Nature Communications is an open-access journal. To publish in Nature Communications, authors are required to pay an article-processing charge (APC). The APC for all published papers is as follows, plus VAT or local taxes where applicable: £3,790 (UK) $5,380 (The Americas, China, and Japan) €4,380 (Europe and rest of world) Nature communications ranking Title Type SJR H index Total Docs. (2018) Total Docs. (3years) Total Refs. (2018) Total Cites (3years) Citable Docs. (3years) Cites / Doc. (2years) Ref. / Doc. (2018) Nature Communications journal 5.992 Q1 248 5664 11692 273530 141425 10983 11.80 48.29 Nature communications details Country: United Kingdom H Index: 248 Subject Area and Category: Biochemistry, Genetics, and Molecular Biology, Biochemistry, Genetics and Molecular Biology (miscellaneous), Chemistry, Chemistry (miscellaneous), Physics and Astronomy, Physics and Astronomy (miscellaneous) Publisher: Nature Publishing Group Publication Type: Journals ISSN: 20411723 Coverage: 2010-ongoing

✅ Asian journal of pharmacy and pharmacology ISSN - ResearchHelpDesk - Asian Journal of Pharmacy and Pharmacology (AJPP) is a bimonthly peer reviewed Journal publishing authentic quality research work and reviews that provides scientific knowledge to the all communities. AJPP (ISSN: 2455-2674) is an official publication of N.S. Memorial Scientific Research and Education Society. Society is registered under M. P. Society Registrikaran Adhiniyam, 1973 (No.44 of 1973). AJPP serves as a messenger for exchange of scientific information between human being and researchers. It provides a podium to the researchers and scientists in all over the world, for the spreading of knowledge in the field of Pharmacy and Pharmacology. Articles having newer findings and research concepts will be given more preference for acceptance. Abstracting and Indexing: Google Scholar, Open J-Gate, National Science Library, Advanced Sciences Index, Indian Science Publication, ResearchBib, Open Academic Journals Index (OAJI), Directory of Research Journals Indexing (DRJI), Genamics JournalSeek, Scientific Indexing Services (SIS), CiteFactor, Chemical Abstracts Service (CAS, a division of the American Chemical Society), ScopeMed, Crossref, WorldCat

OAMJs considered in this article.

ABSTRACT This research analyzes the characteristics of Qualis A1 medical journals in order to set up a critical reflection on the impact of journal evaluation policies on Brazilian scientific production. Identifies editorial characteristics of the A1 journals in the areas of Medicina I, Medicina II and Medicina III through a qualitative-quantitative analysis, in order to draw a profile of these journals. The information was extracted from the following systems: Sucupira, Ulrichsweb, DOAJ, Scimago Journal Rank and Journal Citation Reports. The results for the profile of the journals were homogeneous among the three medical areas, and demonstrated that they are mainly published by commercial entities with the predominance of the publisher Elsevier; the median of the unified factor (Journal Impact Factor or Cites per Doc) is 5,365; the frequency of publishing is monthly; they are 45 years old; 13% are Open Access; the predominant country is the United States and that the English language is almost unanimous. It concludes that the observed editorial characteristics reflect the hegemony of commercial conglomerates in the academic publishing market, and that the Brazilian journals, mostly of Open Access and financed by public resources, are unable to compete with the journals of these companies.

International Journal of Surgery Impact Factor 2024-2025 - ResearchHelpDesk - The International Journal of Surgery (IJS) is dedicated to the global advancement of surgical research, education and clinical practice. It aims to promote continued developments in surgery through the sharing of knowledge, ideas and good practice across all surgical specialties. The IJS provides readers with critically peer-reviewed, carefully selected/edited and up to date publications about advances in the field of surgery that are relevant to them. The journal aims to develop and uphold the highest standards at the cutting-edge of research, provide a focus for evidence-based medicine through the publication of timely review articles and special issues and give the findings context, through the publication of editorials, commentaries and letters from the surgical community. We enforce reporting guidelines and mandate the registration of all research involving human participants in a publicly accessible research registry. As a broad scope journal covering all surgical specialities, the IJS aims to facilitate the transfer of important ideas and lines of thought between and across specialities. In this way, the journal will help prevent the trend of increasing sub-specialisation leading to 'tunnel-vision' and the sequestration of important surgical advances within particular specialties. The journal is published monthly and focuses on rapid submission to decision times. We provide open access options. All articles are made open access two-years after publication in our delayed open archive, maximising the long-term visibility, impact and influence of our content. We also recognise the efforts of peer-reviewers and publish their reviews (anonymously), which are indexed in PubMed along with the articles content. The Harold Ellis Prize in Surgery The International Journal of Surgery awards the prestigious annual Harold Ellis Prize (Est. 2003) in recognition of scientific papers judged to be outstanding. For terms and conditions, and details on how to apply, please click on the link. Indexed and Abstracted AcademicPub The British Library Cancerlit EMBASE Google Scholar Medline/PubMed ProQuest Science Citation Index Expanded Scopus Scisearch Web of Science Emerging Sources Science Citation Index

Quantity of citations for Covid-19 and non-Covid-19 articles with median and range values across all fields.

Citation overview of each OAMJ for articles published in 2013.